Index
240
pharmacology, 61, 74
pharmacotherapy, 89
phenolic compounds, 146, 147, 153, 156,
157, 158, 160
phenotype, 165, 167, 168, 169, 171, 174,
179, 180, 188, 194
phocomelia, 178, 190
phosphate, 33, 150
phosphorous, 176
phosphorylation, 3, 5, 15
physical activity, 82, 84, 85, 86, 88
physical therapy, 184
physicians, 187
physiology, 37, 43
pilot study, 65, 67, 91, 120, 121, 220, 221
placebo, 42, 71, 88, 90, 92, 93, 94, 96, 97,
120, 121, 122, 123
placenta, 180
plants, 146, 147, 152, 153, 159, 161
plaque, 148
plasma levels, 38, 40, 43
plasma proteins, 36
plasticity, 132, 139, 141, 142
platelets, 7
pleasure, 105
PM, 196, 216
point mutation, 192
polarity, 149, 166
policy, 30, 128
pollicized, 185, 186
polycystic ovarian syndrome, 92, 109
polydactyly, 168, 173, 174, 179, 185, 186,
191, 194
polyhydramnios, 28
polymorphisms, 192, 203
polyphenols, 156
population, 2, 6, 9, 28, 32, 59, 60, 70, 82,
88, 91, 111, 189, 190, 191, 200, 203,
205, 208, 219
positive feedback, 169, 194
positive relationship, 82
potassium, 28
potential benefits, 181
PRC, 14, 16, 18
preeclampsia, 27
pregnancy, 23, 24, 25, 26, 27, 28, 29, 30,
31, 32, 35, 39, 42, 43, 44, 45, 60, 64, 65,
71, 75, 105, 111, 132, 176, 177, 178,
180, 181, 183, 191, 192, 193, 195
prematurity, 180, 189
premenstrual syndrome, 41
preschool children, 78, 116
preservative, 208, 221
preterm delivery, 28
preterm infants, 31
prevalence of exfoliation, 205
prevalence of XFS, 205
prevention, 11, 19, 68, 81, 86, 87, 192, 214
primary open-angle glaucoma (POAG),
200, 202, 205, 208, 209, 210, 211, 212,
213, 214, 219, 220, 222, 223, 224
primary school, 79, 82, 85, 86
primary tumor, 5
priming, 40
principles, 158
probability, 25, 29, 209, 212
professionals, 81, 103, 184
progesterone, 35, 36, 37, 38, 39, 40, 49, 50,
52, 53, 59, 61, 66, 67, 71, 129, 130, 133,
139, 143
progestin, 36, 37, 38, 39, 40, 41, 44, 49, 50,
51, 52, 53, 54, 55, 56, 57, 58, 59, 61, 62,
67, 68, 69, 70, 74, 75, 139
prognosis, 4, 20, 22, 204, 206
programming, 175
progression rate of XFG, 202
project, 115
prolactin, 32, 132, 134, 141
proliferation, 2, 4, 6, 7, 14, 17, 19, 38, 44,
50, 58, 74, 165, 175
promoter, 2, 15, 16, 17, 18, 21
prostaglandin, 207
prostaglandin analogues, 206
prostate cancer, 16, 18, 22
proteasome, 143
protection, 40, 47, 50, 68, 203
proteins, 4, 14, 15, 16, 17, 18, 36, 139, 169,
170, 174, 178, 194, 195
prothrombin, 57
psychopharmacology, 71